There are a trove of new companies breaking into the healthcare space with new and innovative solutions. And many of these are well-funded to the tune of several million dollars through venture capital funding.
CB Insights listed 150 of the “most promising private companies” with new products and services in the healthcare space with its first-ever Digital Health 150. The companies were chosen from a pool of more than 5,000 and were assessed on several factors, such as patent activity, investor profile, sentiment analysis, market potential, tech novelty and more.
The group represents $17.5 billion in funding from more than 500 equity deals. The funding came from over 850 unique investors, with F-Prime Capital, New Enterprise Associates and Google Ventures being the most active investors. Of the selected companies, 116 were located in the U.S., while 17 were from Asia, 16 from Europe and 1 from Canada.
The most well-funded companies include:
- Grail, a biotech company that seeks to detect cancer early––$1.6 billion in funding
- Oscar Health, a tech-focused health insurance provider––$1.27 billion
- We Doctor, a China-based tech-enabled healthcare solutions platform––$1 billion
- 23andMe––$791 million
- Babylon Health––$635 million
- HeartFlow––$532 million
- Tempus––$520 million
- American Well––$507 million
- Proteus Digital Health––$474 million
- Bright Health––$440 million
See the full Digital Health 150 here.